Search clinical trials for: First episode Bipolar Disorder

Total 161140 results

AstraZeneca

Terminated

Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder (POLARIS)

Bipolar Disorder | Sub-syndromal Symptoms

France
Medical University of Lodz

Unknown

Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia (OFFER)

Schizophrenia

Poland
Fundación Pública Andaluza Progreso y Salud
Instituto de Salud Carlos III

Unknown

Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (NONSTOP)

Psychosis Nos/Other

Spain
Aarhus University Hospital

Completed

Metabolic Syndrome in Patients With First-episode Schizophrenia

Schizophrenia | Metabolic Syndrome X

Denmark
Serge Beaulieu
Bristol-Myers Squibb

Terminated

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

Bipolar Disorder | Depressive Episode

Canada
Janssen Pharmaceutica N.V., Belgium

Completed

A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

China, Taiwan, Colombia, India, Malaysia, Russian Federation, South Africa, Greece, Peru, Germany, Mexico, Lebanon, Indonesia, Philippines, Jordan
Janssen Cilag N.V./S.A.

Completed

A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode

Schizophrenia

South Africa
Bial - Portela C S.A.

Terminated

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder

BIPOLAR I DISORDER
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder

Bipolar I Disorder
University of Ottawa
The Ottawa Hospital

Unknown

Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia

First Episode Schizophrenia

Canada
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Bipolar I Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Bipolar I Disorder

Taiwan, Korea, Republic of, Japan, China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Bipolar I Disorder

Taiwan, Korea, Republic of, Japan, China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Bipolar I Disorder

Taiwan, Korea, Republic of, Japan, China
Kaohsiung Kai-Suan Psychiatric Hospital

Completed

Predictors of the Response and Relapse/Recurrence After ECT for Depressed Patients

Major Depressive Episode

Taiwan
Peking University
Shanghai Mental Health Center; West China Hospital; Central South University; Capital... and other collaborators

Unknown

A Comprehensive Assessment and Follow up Descriptive Study on Bipolar Disorder (CAFE-BD)

Bipolar Disorder | Unipolar Disorder

China
University of Cincinnati
AstraZeneca

Completed

A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder

Bipolar I Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode

Bipolar Disorder

United States, Puerto Rico
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Bipolar I Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Withdrawn

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Bipolar Disorder

United States, India
Academisch Medisch Centrum - Universiteit van Amsterdam...
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial

Schizophrenia

Netherlands
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Improving Work Outcome in People With Recent-onset Schizophrenia

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

Bipolar Disorder

United States, Ukraine, Taiwan, Spain, Poland, India, Malaysia, Russian Federation, Slovakia, Austria
The Medical Research Network
Pfizer; Liebowitz, Michael R., M.D.

Completed

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

Major Depressive Episode | Bipolar II Disorder

United States
Tri-Service General Hospital

Completed

Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder (OCTLPODEPWBD)

Bipolar Disorder

Taiwan
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH)

Completed

Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis

Psychotic Disorders | Schizophrenia

United States
Si Tianmei

Unknown

A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Sexual Dysfunction | Hyperprolactinemia

China
GlaxoSmithKline

Completed

Lamotrigine Pregnancy Registry (LAM05)

Epilepsy | Bipolar Disorder
Universita di Verona

Completed

A Large Pragmatic Cluster Randomized Controlled Trial of a Multi-element Psychosocial Intervention for Early Psychosis (GETUP-PIANO)

Psychosis

Italy
AstraZeneca
University of North Carolina

Completed

CAFE Comparison of Atypicals in First Episode of Psychosis

Mental Disorders | Psychotic Disorders | Schizophrenia | Mental Health

United States, Canada
Northwell Health

Completed

A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis

Smoking | Psychosis

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole Open-Label, Safety and Tolerability Study (APEX 241)

Schizophrenia | Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Bipolar Disorder

United States
Sheba Medical Center

Completed

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode

Mania

Israel, Romania
Xijing Hospital

Unknown

Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients (rTMSfMRI)

Schizophrenia

China
Chonbuk National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Aripiprazole in First Episode Psychosis

First Episode Psychosis

Korea, Republic of
McMaster University
Canadian Institutes of Health Research (CIHR); AstraZeneca; Ontario Mental Health...

Unknown

Longitudinal Study of People Presenting for First Treatment of a Mood Disorder

Bipolar Disorder | Major Depression

Canada
Northwell Health
National Institute of Mental Health (NIMH); The Zucker Hillside Hospital

Completed

Treatment for First-Episode Schizophrenia

Schizophrenia

United States
University of British Columbia

Completed

Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

Canada
University of Regensburg
AstraZeneca

Completed

Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients

Schizophrenia

Germany
Birte Glenthoj
Rigshospitalet, Denmark; University of Copenhagen; Hvidovre University Hospital; The Novo Nordic Foundation and other collaborators

Completed

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
Birte Glenthoj
AstraZeneca; Rigshospitalet, Denmark; University of Copenhagen; Glostrup University... and other collaborators

Completed

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
Eli Lilly and Company

Completed

A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers

Bipolar Disorder

Singapore
Institut fuer anwendungsorientierte Forschung und...
University of Göttingen

Completed

Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study

Schizophrenia

Germany
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.

Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder

Bipolar Disorder | Mania | Affective Psychosis, Bipolar
Hoag Memorial Hospital Presbyterian
Cancer Biotherapy Research Group

Completed

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

Lymphoma | Leukemia

United States
University of North Carolina, Chapel Hill
Eli Lilly and Company

Completed

Study of Amantadine for Weight Stabilization During Olanzapine Treatment

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder | Mood Disorders With Psychotic Features

United States
AstraZeneca

Completed

European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes

Acute Bipolar Manic Episode

Croatia, Italy, Turkey, United Kingdom, Germany, Belgium, Finland, Denmark

Search clinical trials for: First episode Bipolar Disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations